Aspen Pharmacare Total Liabilities 2017-2023 | APNHY
Aspen Pharmacare total liabilities from 2017 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Aspen Pharmacare total liabilities for the quarter ending June 30, 2023 were $2.710B, a 27.04% decline year-over-year.
- Aspen Pharmacare total liabilities for 2023 were $2.71B, a 1.86% increase from 2022.
- Aspen Pharmacare total liabilities for 2022 were $2.66B, a 7.38% decline from 2021.
- Aspen Pharmacare total liabilities for 2021 were $2.873B, a 30.25% decline from 2020.
Aspen Pharmacare Annual Total Liabilities
(Millions of US $) |
| 2023 |
$2,710 |
| 2022 |
$2,660 |
| 2021 |
$2,873 |
| 2020 |
$4,119 |
| 2019 |
$4,801 |
| 2018 |
$6,462 |
| 2017 |
$5,380 |
| 2016 |
$4,289 |
| 2015 |
$ |
Aspen Pharmacare Quarterly Total Liabilities
(Millions of US $) |
| 2023-06-30 |
$2,710 |
| 2022-06-30 |
$2,660 |
| 2021-12-31 |
$2,950 |
| 2021-06-30 |
$2,873 |
| 2020-12-31 |
$3,714 |
| 2020-06-30 |
$4,119 |
| 2019-06-30 |
$4,801 |
| 2018-12-31 |
$5,769 |
| 2018-06-30 |
$6,462 |
| 2017-12-31 |
$5,748 |
| 2017-06-30 |
$5,380 |
| 2016-12-31 |
$4,918 |
| 2016-06-30 |
$4,289 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$5.574B |
$2.296B |
|
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
|
